Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8)

被引:11
|
作者
Wang, Li [1 ]
Sweet, Douglas H. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA 23298 USA
关键词
ROSMARINIC ACID; KNOCKOUT MICE; PLASMA; FAMILY; PHARMACOKINETICS; PHARMACOLOGY; SPECIFICITY; METABOLISM; CLEARANCE; CHEMISTRY;
D O I
10.1155/2012/872458
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Many active components of herbal products are small organic anions, and organic anion transporters were previously demonstrated to be a potential site of drug-drug interactions. In this study, we assessed the inhibitory effects of six hydrophilic components of the herbal medicine Danshen, lithospermic acid, protocatechuic acid, rosmarinic acid, salvianolic acid A, salvianolic acid B, and tanshinol, on the function of the murine organic anion transporters, mOat1 and mOat3. All of Danshen components significantly inhibited mOat1- and mOat3-mediated substrate uptake (P < 0.001) with lithospermic acid (LSA), protocatechuic acid, rosmarinic acid (RMA), and salvianolic acid A (SAA) producing virtually complete inhibition under test conditions. Kinetic analysis demonstrated that LSA, RMA, and SAA were competitive inhibitors. As such, K-i values were estimated as 14.9 +/- 4.9 mu M for LSA, 5.5 +/- 2.2 mu M for RMA, and 4.9 +/- 2.2 mu M for SAA on mOat1-mediated transport, and as 31.1 +/- 7.0 mu M for LSA, 4.3 +/- 0.2 mu M for RMA, and 21.3 +/- 7.7 mu M for SAA on mOat3-mediated transport. These data suggest that herb-drug interactions may occur in vivo on the human orthologs of these transporters in situations of polypharmacy involving Danshen and clinical therapeutics known to be organic anion transporter substrates.
引用
收藏
页数:8
相关论文
共 42 条
  • [41] Organic anion transporter 1 (OAT1/SLC22A6) enhances bioluminescence based on D-luciferin luciferase reaction in living cells by facilitating the intracellular accumulation of D-luciferin
    Furuya, Takahito
    Takehara, Issey
    Shimura, Asuka
    Kishimoto, Hisanao
    Yasujima, Tomoya
    Ohta, Kinya
    Shirasaka, Yoshiyuki
    Yuasa, Hiroaki
    Inoue, Katsuhisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2152 - 2157
  • [42] Limited Brain Distribution of [3R,4R,5S]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4)
    Ose, Atsushi
    Ito, Mototsugu
    Kusuhara, Hiroyuki
    Yamatsugu, Kenzo
    Kanai, Motomu
    Shibasaki, Masakatsu
    Hosokawa, Masakiyo
    Schuetz, John D.
    Sugiyama, Yuichi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 315 - 321